{"id":1610,"date":"2023-06-25T17:27:16","date_gmt":"2023-06-25T17:27:16","guid":{"rendered":"https:\/\/kidneydiseaseclinic.net\/kdc\/acitretin\/"},"modified":"2023-06-25T19:55:46","modified_gmt":"2023-06-25T19:55:46","slug":"acitretin","status":"publish","type":"post","link":"https:\/\/kidneydiseaseclinic.net\/kdc\/acitretin\/","title":{"rendered":"Acitretin"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/kidneydiseaseclinic.net\/renaldrugs\/img\/Acitretin.JPG\"><\/p>\n<h1>Acitretin<\/h1>\n<h3>  CLINICAL USE<\/h3>\n<li>Severe extensive psoriasis, palmoplantarpustular psoriasis<\/li>\n<li>Severe congenital ichthyosis<\/li>\n<li>Severe Darier\u2019s disease<br \/>\n<h3> DOSE IN NORMAL RENAL FUNCTION<\/h3>\n<\/li>\n<li>Initially: 25\u201330 mg daily (Darier\u2019s disease10 mg daily) for 2\u20134 weeks, adjusted<br \/>\naccording to response<\/li>\n<li>Ongoing: usually 25\u201350 mg\/day(maximum 75 mg) for further 6\u20138 weeks.<br \/>\n(In Darier\u2019s disease and ichthyosis not<br \/>\nmore than 50 mg daily for up to 6 months)<\/p>\n<h3>  PHARMACOKINETICS<\/h3>\n<\/li>\n<li> Molecular weight &nbsp;  &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; :<br \/>\n326.4<\/li>\n<li>  %Protein binding  &nbsp; &nbsp; &nbsp;  &nbsp;  &nbsp;  &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; :<br \/>\n&gt;99 (&lt; 0.1% present<br \/>\nas unbound drug<br \/>\nin pooled human<br \/>\nplasma)<\/li>\n<li>  %Excreted unchanged in urine &nbsp; &nbsp; :<br \/>\nExcreted as<br \/>\nmetabolites<\/li>\n<li> Volume of distribution (L\/kg) &nbsp; &nbsp; &nbsp; :<br \/>\n9<\/li>\n<li>half-life \u2013 normal\/ESRD (hrs)&nbsp; &nbsp; &nbsp; :<br \/>\n50\/\u2013<\/p>\n<h3>  DOSE IN RENAL IMPAIRMENT<\/h3>\n<h4>GFR (mL\/MIN)<\/h4>\n<\/li>\n<li> 20 to 50  &nbsp; &nbsp; : No data available. Assume dose as in<br \/>\nnormal renal function<\/li>\n<li> 10 to 20  &nbsp; &nbsp; : No data available. Assume dose as in<br \/>\nnormal renal function<\/li>\n<li> &lt;10 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; :<br \/>\nNo data available. Assume dose as in<br \/>\nnormal renal function<\/p>\n<h3> DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES<\/h3>\n<\/li>\n<li> CAPD  &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;:<br \/>\nUnlikely to be dialysed. Dose as in<br \/>\nnormal renal function<\/li>\n<li> HD &nbsp;  &nbsp; &nbsp;  &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; :<br \/>\nNot dialysed. Dose as in normal renal function<\/li>\n<li>HDF\/high flux  &nbsp; :<br \/>\nUnlikely to be dialysed. Dose as in<br \/>\nnormal renal function<\/li>\n<li>CAV\/VVHD  &nbsp; &nbsp; &nbsp;:<br \/>\nUnknown dialysability. Dose as in<br \/>\nnormal renal function<\/p>\n<h3> IMPORTANT DRUG INTERACTIONS<\/h3>\n<p>Potentially hazardous interactions with other drugs<\/li>\n<li>Antibacterials: possibly increased risk ofbenign intracranial hypertension with<br \/>\ntetracyclines \u2013 avoid concomitant use<\/li>\n<li>Anticoagulants: possible antagonism of theanticoagulant effect of coumarins<\/li>\n<li>Cytotoxics: increased concentrationof methotrexate (also increased risk of<br \/>\nhepatotoxicity) \u2013 avoid concomitant use<\/p>\n<h3> ADMINISTRATION<\/h3>\n<h4> Reconstition<\/h4>\n<p>\u2013<\/p>\n<h4>  Route<\/h4>\n<p>Oral<\/p>\n<h4>  Rate of Administration<\/h4>\n<p>\u2013<\/p>\n<h4>Comments<\/h4>\n<p>Take once daily with meals or with milk<\/p>\n<h4>  OTHER INFORMATION<\/h4>\n<p>Manufacturer\u2019s literature contraindicates<\/p>\n<p>the use of acitretin in renal failure<\/li>\n","protected":false},"excerpt":{"rendered":"<p>Acitretin CLINICAL USE Severe extensive psoriasis, palmoplantarpustular psoriasis Severe congenital<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[7],"class_list":["post-1610","post","type-post","status-publish","format-standard","hentry","category-blog","tag-post-by-auto-php"],"_links":{"self":[{"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/posts\/1610","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/comments?post=1610"}],"version-history":[{"count":1,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/posts\/1610\/revisions"}],"predecessor-version":[{"id":2908,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/posts\/1610\/revisions\/2908"}],"wp:attachment":[{"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/media?parent=1610"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/categories?post=1610"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/tags?post=1610"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}